Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds

Endocrinology

Volumn 140, Issue 6, 1999, Pages 2891-2897

  Nnane, Ivo P ^a   Kato, Katsuya ^a,b   Liu, Yang ^a   Long, Brian J ^a   Lu, Qing ^a   Wang, Xin ^a   Ling, Yang Zhi ^a,c   Brodie, Angela ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

17 (4' IMIDAZOLYL)ANDROSTA 4,16 DIEN 3 ONE; 17 (5' ISOXAZOLYL)ANDROSTA 5,16 DIEN 3BETA OL; 17BETA (4' IMIDAZOLYL)ANDROST 5 EN 3BETA OL; 3BETA ACETOXY 17 (4' IMIDAZOLYL)ANDROSTA 5,16 DIENE; 4,16 PREGNADIENE 3,20 DIONE 20 OXIME ACETATE; ANDROGEN; ANDROSTANOLONE; FINASTERIDE; I 47; KETOCONAZOLE; L 12; L 26; L 38; L 6; LYASE; STEROID; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CASTRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN SYNTHESIS INHIBITION; RAT; TESTIS; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033279386     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.6.6832     Document Type: Article

References (31)

1. Prostate Cancer
2. Epidemiology of prostate cancer
3. The conversion of testosterone to 5α-androsta-17α-ol-3-one by rat prostate in vivo and in vitro
4. Some aspects of relation of structure of steroids to their prostate stimulating effects
5. Role of dihydrotestosterone in androgen action
6. Male pseudohemaphroditism due to steroid 5-α-reductase deficiency
7. New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens
8. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
9. 17,20lyase)
10. Inhibition of testicular 17α-hydroxylase and 17,20-lyase but not 3-hydroxysteroid dehydrogenase - Isomerase or 17-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs
11. 17,20lyase)
12. 17 heteroaryl steroids
13. Novel inhibitors of enzymes of androgen biosynthesis
14. 17,20lyase): Potential agents for the treatment of prostate cancer
15. Ketoconazole therapy in advanced prostatic cancer
16. Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal
17. Inhibition of steroid 5α-reductase with finasteride: Sleep related erections, potency and libido in healthy men
18. Finasteride; a review of its potential in the treatment of benign prostatic hyperplasia
19. Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one
20. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis
21. 17,20lyase and of 5α-reductase
22. 17α)
23. 17,20lyase
24. 17α): Potent inhibitors for the treatment of prostate cancer
25. Protein measurement with the folin phenol reagent
26. Inhibition of androgen synthesis by some novel 17-azolyl steroids and their potential role in the treatment of prostate cancer
27. 17,20-lyase and 5α-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer
28. Inhibition of rat prostate carcinogenesis by a 5α-reductase inhibitor, FK143
29. Evidence of atrophy and apoptosis in the ventral prostate of rats given the 5α-reductase inhibitor finasteride
30. Selective inhibition of prostatic tumour 5α-reductase by a 4-methyl-4-azasteroid
31. In vitro and in vivo inhibition of LNCaP prostate cancer cell growth by novel inhibitors of androgen synthesis